Skip to main content

Table 2 Exposure to any TNFi by pediatric patients at CoA residing in Alabama

From: Risk of tuberculosis among Alabama children and adolescents treated with tumor necrosis factor inhibitors: a retrospective study

Characteristic Value
n 1033
Age at initial usage (median, IQR) 13.0 (9.2–15.8)
Years of exposure (median, IQR) 1.0 (0.17–2.4)
Female 592 (57%)
Race
 Caucasian 771 (75%)
 African-American 251 (24%)
 Other / unknown 11 (1.1%)
Number of TNF inhibitors used
 1 768 (74%)
 2 227 (22%)
 3 37 (3.6%)
 4 1 (0.1%)
Diagnosis
 JIAa 544
 IBDa 265
 IBD with JIAa 69
 Vasculitis 33
 Uveitis 31
 Psoriasis 29
 Sarcoidosis 17
 Mixed connective tissue disease / SLE 13
 Sjogren Syndrome 7
 Recurrent fever syndrome 6
 Behcet Syndrome 5
 Hidradenitis 3
 Juvenile dermatomyositis 3
 Non-infectious osteomyelitis 3
 Sensorineural hearing loss 2
 Otherb 3
Cases of Tuberculosis 1
  1. Abbreviations: IBD inflammatory bowel disease, JIA Juvenile idiopathic arthritis, SLE systemic lupus erythematosus
  2. aIncludes subjects with uveitis, psoriasis, or both
  3. bIncludes one each of chronic granuloma annulare, pityriasis rubra pilaris, and orbital pseudotumor